JP2004529179A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004529179A5 JP2004529179A5 JP2002589032A JP2002589032A JP2004529179A5 JP 2004529179 A5 JP2004529179 A5 JP 2004529179A5 JP 2002589032 A JP2002589032 A JP 2002589032A JP 2002589032 A JP2002589032 A JP 2002589032A JP 2004529179 A5 JP2004529179 A5 JP 2004529179A5
- Authority
- JP
- Japan
- Prior art keywords
- ntp
- segment
- pharmaceutical composition
- mfallil
- tharlil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29097101P | 2001-05-16 | 2001-05-16 | |
| PCT/CA2002/000712 WO2002092115A2 (en) | 2001-05-16 | 2002-05-16 | Method of preventing cell death using segments of neural thread proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004529179A JP2004529179A (ja) | 2004-09-24 |
| JP2004529179A5 true JP2004529179A5 (enExample) | 2006-01-05 |
Family
ID=23118262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002589032A Ceased JP2004529179A (ja) | 2001-05-16 | 2002-05-16 | 神経線維タンパク質のセグメントを使用する細胞死の予防法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7572450B2 (enExample) |
| EP (1) | EP1392347B1 (enExample) |
| JP (1) | JP2004529179A (enExample) |
| KR (1) | KR20040008177A (enExample) |
| CN (1) | CN1558770A (enExample) |
| AT (2) | ATE381342T1 (enExample) |
| BR (1) | BR0209630A (enExample) |
| CA (1) | CA2446945A1 (enExample) |
| DE (2) | DE60205366T2 (enExample) |
| DK (1) | DK1392347T3 (enExample) |
| ES (1) | ES2247329T3 (enExample) |
| WO (1) | WO2002092115A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7259232B1 (en) * | 2000-10-27 | 2007-08-21 | Nymox Pharmaceutical Corporation | Preferred segments of neural thread protein |
| BR0209990A (pt) * | 2001-05-25 | 2004-06-29 | Nymox Corp | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células |
| US7317077B2 (en) * | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| US7544771B2 (en) * | 2005-02-23 | 2009-06-09 | Nymox Corporation | Protein and its use in diagnosing Alzheimer's disease |
| US20160361380A1 (en) * | 2015-06-12 | 2016-12-15 | Nymox Corporation | Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations |
| US11628202B2 (en) | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
| US10183058B2 (en) | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
| US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
| US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
| US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0378924B1 (en) * | 1988-12-21 | 1996-11-13 | The General Hospital Corporation | Detection of neurological disease or dysfunction |
| US5948634A (en) * | 1988-12-21 | 1999-09-07 | The General Hospital Coporation | Neural thread protein gene expression and detection of alzheimer's disease |
| KR100392244B1 (ko) | 1993-04-20 | 2003-11-28 | 더 제너럴 호스피탈 코포레이션 | 신경사단백질유전자발현및알쯔하이머병의검출 |
| CN1300778A (zh) * | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | 一种新的多肽－人神经元线蛋白15和编码这种多肽的多核苷酸 |
| CN1300779A (zh) | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | 一种新的多肽－人神经元线蛋白17和编码这种多肽的多核苷酸 |
| US7259232B1 (en) * | 2000-10-27 | 2007-08-21 | Nymox Pharmaceutical Corporation | Preferred segments of neural thread protein |
| DE60222745T2 (de) * | 2001-03-08 | 2008-07-10 | Nymox Pharmaceutical Corp., St. Laurent | Verwendung von neurofilamentproteinen zur behandlung von tumoren |
-
2002
- 2002-05-16 JP JP2002589032A patent/JP2004529179A/ja not_active Ceased
- 2002-05-16 DE DE60205366T patent/DE60205366T2/de not_active Expired - Fee Related
- 2002-05-16 US US10/146,130 patent/US7572450B2/en not_active Expired - Fee Related
- 2002-05-16 DK DK02729699T patent/DK1392347T3/da active
- 2002-05-16 CN CNA02814029XA patent/CN1558770A/zh active Pending
- 2002-05-16 BR BR0209630-7A patent/BR0209630A/pt not_active IP Right Cessation
- 2002-05-16 AT AT05003125T patent/ATE381342T1/de not_active IP Right Cessation
- 2002-05-16 ES ES02729699T patent/ES2247329T3/es not_active Expired - Lifetime
- 2002-05-16 AT AT02729699T patent/ATE300951T1/de not_active IP Right Cessation
- 2002-05-16 WO PCT/CA2002/000712 patent/WO2002092115A2/en not_active Ceased
- 2002-05-16 DE DE60224231T patent/DE60224231D1/de not_active Expired - Lifetime
- 2002-05-16 CA CA002446945A patent/CA2446945A1/en not_active Abandoned
- 2002-05-16 KR KR10-2003-7014850A patent/KR20040008177A/ko not_active Abandoned
- 2002-05-16 EP EP02729699A patent/EP1392347B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kofke et al. | Isoflurane for refractory status epilepticus: a clinical series | |
| Markarian et al. | Mild hypothermia: therapeutic window after experimental cerebral ischemia | |
| EA200800056A1 (ru) | Каннабиноидный активный фармацевтический ингредиент для лекарственных форм | |
| HRP20230272T1 (hr) | Postupci za liječenje cistične fibroze | |
| JP2005501110A5 (enExample) | ||
| RU94045155A (ru) | Способы ингибирования болезни альцгеймера | |
| RU2008103617A (ru) | Бисфосфоновые кислоты, предназначенные для лечения и профилактики остеопороза | |
| JP2005520780A5 (enExample) | ||
| EP1192949A4 (en) | PREVENTIVE OR THERAPEUTIC DRUGS FOR TREATING FIBROSIS AND CONTAINING CHYMASE INHIBITORS AS ACTIVE INGREDIENTS | |
| BRPI0418973A (pt) | composições de risedronato e seus métodos de uso | |
| CA2313270A1 (en) | Use of deferiprone in treating and preventing iron-induced cardiac disease | |
| BRPI0416882A (pt) | composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto | |
| US20060167026A1 (en) | Antipsychotic molecular-targeting epithelial growth factor receptor | |
| WO2008117730A1 (ja) | 肝疾患の予防または治療用組成物 | |
| UA92498C2 (ru) | Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм | |
| JP2019529569A5 (enExample) | ||
| Van Lancker et al. | The effect of mandibular nerve block on opioidconsumption, nausea and vomiting in bilateral mandibular osteotomies | |
| EP2184284B1 (en) | Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as an active ingredient | |
| JP2003530350A (ja) | 外傷性脳損傷及びその他のニューロン障害治療用医薬 | |
| JPH0415766B2 (enExample) | ||
| Krawczyk et al. | The recommendations for perioperative pain relief in general surgery | |
| CN105963287B (zh) | 复方组合物及其医药用途 | |
| Kennedy et al. | Anesthesia case of the month | |
| TW200724138A (en) | Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use | |
| PO | Cholinergic mechanisms of analgesia |